@ARTICLE{
author={Singer BA,Drulovic Jelena S,Negroski Donald,Selmaj Krzysztof,Bergh Florian Then,Scaramozza M,Castro-Borrero W,Adair H,Chen Hailu,Levin S,Shankar SL,Wray Sibyl},
year={2022},
title={Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: final safety and efficacy results from the phase 3 EVOLVE-MS-1 study},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={28},
number={3_SUPPL},
pages={625-626},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Hupperts Raymond,Drulovic Jelena S,Selmaj Krzysztof,Montalban Xavier,Kostic Smiljana,Valis Martin,Zhang Yiwei,Xu Lei,Mellion Michelle,Cadaviv Diego},
year={2017},
title={Correlation of brain volume and physical measures with cognitive function using baseline data from the anti-LINGO-1 SYNERGY trial in multiple sclerosis},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={23},
number={1},
pages={152-153},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Cadavid Diego,Klistorner Alexander,Ampapa Radek,Bonek Robert,Drulovic Jelena S,Kostic Smiljana,Maciejowski Maciej,Selmaj Krzysztof,Valis Martin,Zielinski Tomasz,Ibrahim Adama,Zhang Yiwei,Xu Lei},
year={2016},
title={Correlation of Physical, Cognitive and MRI Measures with Multifocal Visual Evoked Potential using Baseline Data from the Anti-LINGO-1 SYNERGY Trial in Multiple Sclerosis},
journal={NEUROLOGY},
volume={86},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Hupperts Raymond,Drulovic Jelena S,Selmaj Krzysztof,Montalban Xavier,Kostic Smiljana,Valis Martin,Evdoshenko Evgeniy,Zhang Yiwei,Xu Lei,Mellion Michelle,Cadavid Diego},
year={2016},
title={Correlation of Brain Volume and Physical Measures with Cognitive Function Using Baseline Data from the Anti-LINGO-1 SYNERGY Trial in Multiple Sclerosis},
journal={NEUROLOGY},
volume={86},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Cadaviv Diego,Hupperts Raymond,Drulovic Jelena S,Selmaj Krzysztof,Montalban Xavier,Kostic Smiljana,Valis Martin,Evdoshenko E,Zhang Yiwei,Xu Lei,Mellion Michelle},
year={2015},
title={Correlation of brain volume and physical measures with cognitive function using baseline data from the anti-LINGO-1 SYNERGY trial in multiple sclerosis},
journal={MULTIPLE SCLEROSIS JOURNAL},
volume={21},
number={},
pages={304-304},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Arnold Douglas L,Brinar Vesna,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Fisher Elizabeth,Fox Edward,Giovannoni Gavin,Hartung Hans,Havrdova Eva,Selmaj Krzysztof,Weiner Howard,Stojanovic Miroslav,Lake Stephen,Margolin David,Panzara Michael,Compston Alastair},
year={2012},
title={Effect of Alemtuzumab vs. Rebif (R) on Brain MRI Measurements: Results of CARE-MS I, a Phase 3 Study},
journal={NEUROLOGY},
volume={78},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Havrdova Eva,Arnold Douglas L,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Fox Edward,Hartung Hans,Selmaj Krzysztof,Weiner Howard,Brinar Vesna,Giovannoni Gavin,Stojanovic Miroslav,Lake Stephen,Margolin David,Oyuela Pedro,Panzara Michael,Compston Alastair},
year={2012},
title={Infections in Phase 3 Study: Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I)},
journal={NEUROLOGY},
volume={78},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Selmaj Krzysztof,Arnold Douglas L,Brinar Vesna,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Fox Edward,Giovannoni Gavin,Hartung Hans,Havrdova Eva,Stojanovic Miroslav,Weiner Howard,Lake Stephen,Margolin David,Oyuela Pedro,Panzara Michael,Compston Alastair},
year={2012},
title={Incidence of Autoimmunity in a Phase 3 Trial: Comparison of Alemtuzumab and Rebif (R) in Multiple Sclerosis I (CARE-MS I)},
journal={NEUROLOGY},
volume={78},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Fox Edward,Arnold Douglas L,Brinar Vesna,Cohen Jeffrey,Coles Alasdair,Confavreux Christian,Giovannoni Gavin,Hartung Hans,Havrdova Eva,Selmaj Krzysztof,Stojanovic Miroslav,Weiner Howard,Lake Stephen,Margolin David,Panzara Michael,Compston Alastair},
year={2012},
title={Relapse Outcomes with Alemtuzumab vs. Rebif (R) in Treatment-Naive Relapsing-Remitting Multiple Sclerosis (CARE-MS I): Secondary and Tertiary Endpoints},
journal={NEUROLOGY},
volume={78},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Coles Alasdair,Brinar Vesna,Arnold Douglas L,Cohen Jeffrey,Confavreux Christian,Fox Edward,Hartung Hans,Havrdova Eva,Selmaj Krzysztof,Weiner Howard,Giovannoni Gavin,Stojanovic Miroslav,Lake Stephen,Margolin David,Panzara Michael,Compston Alastair},
year={2012},
title={Efficacy and Safety Results from Comparison of Alemtuzumab and Rebif (R) Efficacy in Multiple Sclerosis I (CARE-MS I): A Phase 3 Study in Relapsing-Remitting Treatment-Naive Patients},
journal={NEUROLOGY},
volume={78},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Nadj Congor G,Nadj Ilinka,Havrdova Eva,Krasulova Eva,Selmaj Krzysztof,Losy Jacek,Radue Ernst-Wilhelm,Gianettoni Jill,Solvason Nanette,Tersini Karen,Valone Frank,Utz Paul J,Robinson William H,Steinman Lawrence,Garren Hideki},
year={2008},
title={Cerebrospinal fluid cell phenotypic analysis from a phase 2 trial of the BHT-3009 DNA vaccine for multiple sclerosis},
journal={MULTIPLE SCLEROSIS},
volume={14},
number={},
pages={S54-S54},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Havrdova Eva,Krasulova Eva,Nadj Congor G,Selmaj Krzysztof,Losy Jacek,Nadj Ilinka,Radue Ernst-Wilhelm,Gianettoni Jill,Valone Frank,Utz Paul J,Robinson William H,Steinman Lawrence,Garren Hideki},
year={2008},
title={Phase 2 follow-up results of the BHT-3009 DNA vaccine for multiple sclerosis},
journal={MULTIPLE SCLEROSIS},
volume={14},
number={},
pages={S47-S47},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Garren Hideki,Robinson William H,Krasulova Eva,Havrdova Eva,Nadj Congor G,Selmaj Krzysztof,Losy Jacek,Nadj Ilinka,Radue Ernst-Wilhelm,Kidd Brian A,Gianettoni Jill,Tersini Karen,Utz Paul J,Valone Frank,Steinman Lawrence},
year={2008},
title={Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis},
journal={ANNALS OF NEUROLOGY},
volume={63},
number={5},
pages={611-620},
document_type={Article},
} 

@ARTICLE{
author={Garren Hideki,Krasulova Eva,Havrdova Eva,Nadj Congor G,Nadj Ilinka,Selmaj Krzysztof,Radue Ernst-Wilhelm,Gianettoni Jill,Tersini Karen,Valone Frank,Robinson William H,Utz Paul J,Steinman Lawrence},
year={2007},
title={Phase IIb trial of a MBP encoding DNA plasmid (BHT-3009) for the treatment of relapsing-remitting multiple sclerosis},
journal={MULTIPLE SCLEROSIS},
volume={13},
number={},
pages={S17-S18},
document_type={Meeting Abstract},
}